Pre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study.
Authors
Crona, JLamarca, Angela
Ronot, M
Opalinska, M
Lopez, C
Pezzutti, D
Trueba, H
Carvhalo, L
de Mestier, L
Najran, Pavan
Pavel, M
Dromain, C
Affiliation
Department of Medical Sciences, Uppsala University, Uppsala, SwedenIssue Date
2018